Direxion Daily S&P Biotech Bull 3X ETF
LABU
21 hedge funds and large institutions have $11.4M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2016 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 2 closing their positions.
450% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 2
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
75% more funds holding
Funds holding: 12 → 21 (+9)
57% more capital invested
Capital invested by funds: $7.27M → $11.4M (+$4.17M)
32% more call options, than puts
Call options by funds: $6.74M | Put options by funds: $5.11M
0.26% more ownership
Funds ownership: 0.05% → 0.31% (+0.26%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.2M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.01M |
| 3 |
VF
Virtu Financial
New York
|
+$1.17M |
| 4 |
CT
CMT Trading
Chicago,
Illinois
|
+$483K |
| 5 |
OPPM
Opus Point Partners Management
New York
|
+$379K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BHA
Beech Hill Advisors
New York
|
-$759K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$118K |
| 3 |
Jane Street
New York
|
-$59.5K |
| 4 |
TCM
Traynor Capital Management
Malvern,
Pennsylvania
|
-$48.1K |
LABU Hedge Fund Activity: Q1 2016 in Review
21 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q1 2016, worth a combined $11.4M — up 57% from $7.27M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new LABU positions and 2 closed out — a net gain of 9 holders — while 6 added to existing stakes and 2 trimmed.
The largest buyer was Tower Research Capital (TRC), adding an estimated $5.2M. The largest seller was Beech Hill Advisors, exiting entirely with an estimated $759K sold.
- 21 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q1 2016, up from 12 in Q4 2015.
- Funds reported $11.4M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q1 2016, up 57% quarter-over-quarter.
- 11 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q1 2016 and 2 closed out, a net change of +9 holders.
- The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q1 2016 was Tower Research Capital (TRC), an estimated $5.2M added.
- The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q1 2016 was Beech Hill Advisors, an estimated $759K sold.
Based on aggregated 13F filings for Q1 2016.